RNA-Seq Analysis Reveals CCR5 as a Key Target for CRISPR Gene Editing to Regulate In Vivo NK Cell Trafficking

SIMPLE SUMMARY: Adoptive immunotherapy utilizing ex vivo expanded natural killer (NK) cells is being explored in the clinical and preclinical settings to treat hematological tumors. Previous work has shown that a large fraction of ex vivo expanded NK cells traffic into the liver following i.v. infus...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Emily R., Clara, Joseph A., Reger, Robert N., Allan, David S. J., Childs, Richard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922167/
https://www.ncbi.nlm.nih.gov/pubmed/33669611
http://dx.doi.org/10.3390/cancers13040872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922167/
https://www.ncbi.nlm.nih.gov/pubmed/33669611
http://dx.doi.org/10.3390/cancers13040872

Ejemplares similares